diphenhydramine has been researched along with Epithelial Neoplasms in 1 studies
Diphenhydramine: A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.
diphenhydramine : An ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug.
antitussive : An agent that suppresses cough. Antitussives have a central or a peripheral action on the cough reflex, or a combination of both. Compare with expectorants, which are considered to increase the volume of secretions in the respiratory tract, so facilitating their removal by ciliary action and coughing, and mucolytics, which decrease the viscosity of mucus, facilitating its removal by ciliary action and expectoration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Background Carboplatin-based chemotherapy offers high response rates and improved overall survival for women with epithelial ovarian cancer, but its use is limited by the occurrence of hypersensitivity reactions." | 3.88 | Prevention of carboplatin-induced hypersensitivity reactions in women with ovarian cancer. ( Bulter, M; Deghan Manshadi, S; Jerzak, KJ; Mackay, HJ; Maganti, M; McCuaig, JM; Ng, P; Oza, A, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jerzak, KJ | 1 |
| Deghan Manshadi, S | 1 |
| Ng, P | 1 |
| Maganti, M | 1 |
| McCuaig, JM | 1 |
| Bulter, M | 1 |
| Oza, A | 1 |
| Mackay, HJ | 1 |
1 other study available for diphenhydramine and Epithelial Neoplasms
| Article | Year |
|---|---|
Prevention of carboplatin-induced hypersensitivity reactions in women with ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino | 2018 |